Using ShatterSeek to define high confidence regions of chromothripsis[7], 25 (60%) of 42 TP53-mutated myeloid malignancies exhibited chromothripsis (Figure 4D, Supplementary Table 5). This evidence concerns the gene TP53 and myeloid neoplasm.